Annual Current Liabilities
$16.46 M
-$8.41 M-33.82%
31 December 2023
Summary:
Armata Pharmaceuticals annual total current liabilities is currently $16.46 million, with the most recent change of -$8.41 million (-33.82%) on 31 December 2023. During the last 3 years, it has risen by +$9.76 million (+145.50%). ARMP annual current liabilities is now -33.82% below its all-time high of $24.87 million, reached on 31 December 2022.ARMP Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$118.20 M
-$4.98 M-4.04%
30 September 2024
Summary:
Armata Pharmaceuticals quarterly total current liabilities is currently $118.20 million, with the most recent change of -$4.98 million (-4.04%) on 30 September 2024. Over the past year, it has increased by +$96.32 million (+440.14%). ARMP quarterly current liabilities is now -4.04% below its all-time high of $123.18 million, reached on 30 June 2024.ARMP Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARMP Current Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -33.8% | +440.1% |
3 y3 years | +145.5% | +2149.8% |
5 y5 years | +540.0% | +2280.8% |
ARMP Current Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -33.8% | +241.9% | -4.0% | +2355.4% |
5 y | 5 years | -33.8% | +540.0% | -4.0% | +2355.4% |
alltime | all time | -33.8% | +1729.0% | -4.0% | >+9999.0% |
Armata Pharmaceuticals Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $118.20 M(-4.0%) |
June 2024 | - | $123.18 M(+11.9%) |
Mar 2024 | - | $110.05 M(+568.5%) |
Dec 2023 | $16.46 M(-33.8%) | $16.46 M(-24.8%) |
Sept 2023 | - | $21.88 M(-57.6%) |
June 2023 | - | $51.56 M(+0.3%) |
Mar 2023 | - | $51.41 M(+106.7%) |
Dec 2022 | $24.87 M(+416.7%) | $24.87 M(+255.1%) |
Sept 2022 | - | $7.00 M(-5.1%) |
June 2022 | - | $7.38 M(+18.6%) |
Mar 2022 | - | $6.23 M(+29.3%) |
Dec 2021 | $4.81 M(-28.2%) | $4.81 M(-8.4%) |
Sept 2021 | - | $5.25 M(-11.0%) |
June 2021 | - | $5.90 M(+18.5%) |
Mar 2021 | - | $4.98 M(-25.7%) |
Dec 2020 | $6.71 M(+37.4%) | $6.71 M(-5.2%) |
Sept 2020 | - | $7.07 M(+35.8%) |
June 2020 | - | $5.21 M(-18.1%) |
Mar 2020 | - | $6.36 M(+30.3%) |
Dec 2019 | $4.88 M(+89.7%) | $4.88 M(-1.7%) |
Sept 2019 | - | $4.96 M(-11.9%) |
June 2019 | - | $5.63 M(+56.9%) |
Mar 2019 | - | $3.59 M(+39.6%) |
Dec 2018 | $2.57 M(+30.7%) | $2.57 M(+4.3%) |
Sept 2018 | - | $2.46 M(+20.3%) |
June 2018 | - | $2.05 M(+15.4%) |
Mar 2018 | - | $1.77 M(-9.8%) |
Dec 2017 | $1.97 M(-44.4%) | $1.97 M(-20.5%) |
Sept 2017 | - | $2.48 M(-33.3%) |
June 2017 | - | $3.71 M(+29.0%) |
Mar 2017 | - | $2.88 M(-18.7%) |
Dec 2016 | $3.54 M(+48.3%) | $3.54 M(+12.2%) |
Sept 2016 | - | $3.15 M(-5.1%) |
June 2016 | - | $3.32 M(+25.4%) |
Mar 2016 | - | $2.65 M(+11.2%) |
Dec 2015 | $2.38 M(+27.7%) | $2.38 M(+5.6%) |
Sept 2015 | - | $2.26 M(+4.2%) |
June 2015 | - | $2.17 M(+2.1%) |
Mar 2015 | - | $2.12 M(+13.6%) |
Dec 2014 | $1.87 M(-21.9%) | $1.87 M(-25.3%) |
Sept 2014 | - | $2.50 M(+82.9%) |
June 2014 | - | $1.37 M(+55.4%) |
Mar 2014 | - | $879.00 K(-63.2%) |
Dec 2013 | $2.39 M(-60.5%) | $2.39 M(+33.1%) |
Dec 2012 | $6.05 M(+51.8%) | - |
Sept 2009 | - | $1.80 M(-10.5%) |
June 2009 | - | $2.01 M(-51.1%) |
Mar 2009 | - | $4.11 M(+3.1%) |
Dec 2008 | $3.99 M(-14.4%) | $3.99 M(-22.5%) |
Sept 2008 | - | $5.14 M(-14.1%) |
June 2008 | - | $5.98 M(+57.3%) |
Mar 2008 | - | $3.80 M(-18.3%) |
Dec 2007 | $4.66 M | $4.66 M(-9.1%) |
Sept 2007 | - | $5.13 M(-22.3%) |
Date | Annual | Quarterly |
---|---|---|
June 2007 | - | $6.60 M(+13.5%) |
Mar 2007 | - | $5.81 M(+12.0%) |
Dec 2006 | $5.19 M(+12.1%) | $5.19 M(-21.0%) |
Sept 2006 | - | $6.57 M(+64.2%) |
June 2006 | - | $4.00 M(+2.1%) |
Mar 2006 | - | $3.92 M(-15.4%) |
Dec 2005 | $4.63 M(+15.8%) | $4.63 M(+25.6%) |
Sept 2005 | - | $3.69 M(-19.5%) |
June 2005 | - | $4.58 M(+13.2%) |
Mar 2005 | - | $4.04 M(+1.2%) |
Dec 2004 | $4.00 M(-40.5%) | $4.00 M(-17.6%) |
Sept 2004 | - | $4.85 M(-41.8%) |
June 2004 | - | $8.33 M(+11.4%) |
Mar 2004 | - | $7.47 M(+11.4%) |
Dec 2003 | $6.71 M(-40.5%) | $6.71 M(-10.2%) |
Sept 2003 | - | $7.47 M(-32.9%) |
June 2003 | - | $11.14 M(+9.3%) |
Mar 2003 | - | $10.20 M(-9.6%) |
Dec 2002 | $11.28 M(-3.0%) | $11.28 M(-9.3%) |
Sept 2002 | - | $12.44 M(+0.5%) |
June 2002 | - | $12.38 M(+26.2%) |
Mar 2002 | - | $9.80 M(-15.7%) |
Dec 2001 | $11.63 M(-8.3%) | $11.63 M(+12.3%) |
Sept 2001 | - | $10.36 M(-4.7%) |
June 2001 | - | $10.86 M(-23.4%) |
Mar 2001 | - | $14.18 M(+11.8%) |
Dec 2000 | $12.69 M(+175.8%) | $12.69 M(+77.4%) |
Sept 2000 | - | $7.15 M(+61.7%) |
June 2000 | - | $4.42 M(+6.6%) |
Mar 2000 | - | $4.15 M(-9.7%) |
Dec 1999 | $4.60 M(+39.4%) | $4.60 M(+43.8%) |
Sept 1999 | - | $3.20 M(0.0%) |
June 1999 | - | $3.20 M(+10.3%) |
Mar 1999 | - | $2.90 M(-12.1%) |
Dec 1998 | $3.30 M(+22.2%) | $3.30 M(+17.9%) |
Sept 1998 | - | $2.80 M(-3.4%) |
June 1998 | - | $2.90 M(-9.4%) |
Mar 1998 | - | $3.20 M(+18.5%) |
Dec 1997 | $2.70 M(-22.9%) | $2.70 M(0.0%) |
Sept 1997 | - | $2.70 M(-3.6%) |
June 1997 | - | $2.80 M(-6.7%) |
Mar 1997 | - | $3.00 M(-14.3%) |
Dec 1996 | $3.50 M(+94.4%) | $3.50 M(+20.7%) |
Sept 1996 | - | $2.90 M(-23.7%) |
June 1996 | - | $3.80 M(+137.5%) |
Mar 1996 | - | $1.60 M(-11.1%) |
Dec 1995 | $1.80 M(+12.5%) | $1.80 M(+38.5%) |
Sept 1995 | - | $1.30 M(0.0%) |
June 1995 | - | $1.30 M(0.0%) |
Mar 1995 | - | $1.30 M(-18.8%) |
Dec 1994 | $1.60 M(+77.8%) | $1.60 M(+23.1%) |
Sept 1994 | - | $1.30 M(-7.1%) |
June 1994 | - | $1.40 M(+55.6%) |
Dec 1993 | $900.00 K | $900.00 K |
FAQ
- What is Armata Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals annual current liabilities year-on-year change?
- What is Armata Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals quarterly current liabilities year-on-year change?
What is Armata Pharmaceuticals annual total current liabilities?
The current annual current liabilities of ARMP is $16.46 M
What is the all time high annual current liabilities for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high annual total current liabilities is $24.87 M
What is Armata Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, ARMP annual total current liabilities has changed by -$8.41 M (-33.82%)
What is Armata Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of ARMP is $118.20 M
What is the all time high quarterly current liabilities for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high quarterly total current liabilities is $123.18 M
What is Armata Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, ARMP quarterly total current liabilities has changed by +$96.32 M (+440.14%)